Provision of a High Throughput Bartonella Platform and Chemiluminescent Immunoassays

Public Health England (PHE) is planning to award a contract for the provision of a chemiluminescent processor and accompanying serology kits for detecting Bartonella henselae IgG and IgM antibodies in human serum and plasma to Launch Diagnostic Ltd. PHE believes that the Vircila automated processor platform is currently the only CE-certified IVDD diagnostic device in the market capable of performing the required indirect chemiluminescent Immunoassay to test for Bartonella henselae IgG and IgM antibodies in human serum and plasma.
CPV-Code: 90733000
Abgabefrist:
Typ: Voluntary ex ante transparency notice
Status: Not applicable
Aufgabe: Health
Vergabestelle:
name: Public Health England
address: Manor Farm Road, Porton Down
postal_code: SP2 0QT
city: Salisbury - UK
country: UK
email: None
phone: +44 2076548000
contact_point:
idate: 28. Juni 2020 23:55
udate: 28. Juni 2020 23:55
doc: 064779_2019.xml
authority_types:
activities:
Quelle: http://ted.europa.eu/udl?uri=TED:NOTICE:064779-2019:TEXT:EN:HTML
Unterlagen: None
Zuschlagskriterium: Not specified
Vertrag: Supplies
Prozedur: Negotiated without a prior call for competition
Nuts: None
Veröffentlichung: 11.02.2019
Erfüllungsort: Salisbury - GB
Link:
Lose:
Name Los Nr 1 None
Gewinner Launch Diagnostics Limited
Datum
Wert GB£500 000,00
Anzahl Angebote 1